Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Endocrine Abstracts · 04.03.2026
DOI: 10.1530/endoabs.116.c20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von Aman Chauhan und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chauhan, A., Kunos, C., Konda, B., Weiss, H., Soares, H., Li, D., MD, Halfdanarson,, T., Mulcahy, M., Khurana, A., Beumer, J., Carson, W., Rubinstein, L., Gore, S., Pelosof,, L., Ivy, P., Kohn, E., Anthony, L., & Arnold, S. (2026). Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.c20
Vancouver
Chauhan A, Kunos C, Konda B, Weiss H, Soares H, Li D, et al. Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.c20
BibTeX
@article{Chauhan2026,
author = {Chauhan, Aman and Kunos, Charles and Konda, Bhawana and Weiss, Heidi and Soares, Heloisa and Li, Daneng and MD and Halfdanarson,, Thorvardur and Mulcahy, Mary and Khurana, Aman and Beumer, Jan and Carson, William and Rubinstein, Lawrence and Gore, Steven and Pelosof,, Lorraine and Ivy, Percy and Kohn, Elise and Anthony, Lowell and Arnold, Susanne},
title = {Multi-center NCI-sponsored phase 1 study of triapine in combination with 177Lu-dotatate in patients with progressive well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs)},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.116.c20}
}
EUVIMED